Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 1b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04882163
What this trial is testing

Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab or Tafasitamab or Rituximab Plus Chemotherapy in B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Celgene
Testing effectiveness (Phase 2)Study completedNCT02603081
What this trial is testing

Study to Evaluate SPI-1005 in Adults With Meniere's Disease

Who this might be right for
Meniere's Disease
Sound Pharmaceuticals, Incorporated 40
Early research (Phase 1)Study completedNCT00815607
What this trial is testing

Trial of an Intratumoral Injections of INXN-3001 in Subjects With Stage III or IV Melanoma

Who this might be right for
Melanoma
Alaunos Therapeutics 12
Testing effectiveness (Phase 2)Looking for participantsNCT06128551
What this trial is testing

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)Colorectal CancerPancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc. 534
Early research (Phase 1)Study completedNCT05585307
What this trial is testing

Study of Novel Antiretrovirals in Participants With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 49
Early research (Phase 1)Active Not RecruitingNCT06602232
What this trial is testing

DR-01 in Subjects With Alopecia Areata and Vitiligo

Who this might be right for
Alopecia AreataVitiligo
Dren Bio 81
Early research (Phase 1)Active Not RecruitingNCT06120075
What this trial is testing

AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies

Who this might be right for
Advanced Cancer
Arcus Biosciences, Inc. 91
Testing effectiveness (Phase 2)Looking for participantsNCT06897930
What this trial is testing

Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

Who this might be right for
Lupus Erythematosus, Systemic
AstraZeneca 150
Early research (Phase 1)Study completedNCT03203499
What this trial is testing

Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol

Who this might be right for
Healthy Volunteers
Amygdala Neurosciences, Inc. 48
Testing effectiveness (Phase 2)Looking for participantsNCT05405595
What this trial is testing

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced/Metastatic Solid Tumors
Adagene Inc 186
Early research (Phase 1)Study completedNCT01716312
What this trial is testing

Omalizumab for Lupus

Who this might be right for
Systemic Lupus ErthematosusSjogren's Syndrome
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 17
Early research (Phase 1)Looking for participantsNCT05912075
What this trial is testing

Preoperative Radiotherapy And ASTX660 in Rectum Cancer

Who this might be right for
Locally-advanced Rectal Cancer
Gustave Roussy, Cancer Campus, Grand Paris 78
Early research (Phase 1)Study completedNCT02063607
What this trial is testing

The Study of Safety, Pharmacokinetics, Pharmacodynamics of Peglamda (Peginterferon Lamda 1) on Healthy Volunteers and the Preliminary Evaluation of Peglamda and Hepasig (Ribavirin) Treatment's Effects on Chronic Hepatitis C Patients

Who this might be right for
Hepatitis C
Nanogen Pharmaceutical Biotechnology Joint Stock Company 60
Early research (Phase 1)WithdrawnNCT06260267
What this trial is testing

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Ferring Pharmaceuticals
Early research (Phase 1)Looking for participantsNCT07520292
What this trial is testing

Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder

Who this might be right for
Alcohol Use Disorder
Newleos Therapeutics, Inc. 50
Early research (Phase 1)Active Not RecruitingNCT04750954
What this trial is testing

Testing the Addition of An Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Pancreatic Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Neoplasm
National Cancer Institute (NCI) 29
Testing effectiveness (Phase 2)Looking for participantsNCT04458545
What this trial is testing

Clinical Trials of Multivalent Opioid Vaccine Components

Who this might be right for
Opioid-use Disorder
New York State Psychiatric Institute 45
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Testing effectiveness (Phase 2)Ended earlyNCT04931862
What this trial is testing

Study of WVE-004 in Patients With C9orf72-associated Amyotrophic Lateral Sclerosis (ALS) or Frontotemporal Dementia (FTD)

Who this might be right for
ALSFTD
Wave Life Sciences USA, Inc. 35
Early research (Phase 1)Study completedNCT01814826
What this trial is testing

Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older

Who this might be right for
Acute Myelogenous Leukemia
Millennium Pharmaceuticals, Inc. 64
Next Page